Pharmacy

Home Pharmacy
In a Society for Healthcare Epidemiology of America white paper

SHEA Updates Guidance for Health Care Staff With Hepatitis, HIV

Career counseling recommended for those planning to conduct exposure-prone procedures
Tocilizumab may be beneficial for adults with COVID-19 admitted to the intensive care unit

Findings Conflicted for Benefit of Tocilizumab in COVID-19

One trial shows reduction in mortality, but no evidence of efficacy seen in two additional trials
For patients with psoriasis

Survival From COVID-19 High in Patients With Psoriasis

Risk for hospitalization increased for patients using nonbiologic systemic therapy versus biologics
For patients with moderate COVID-19

Convalescent Plasma Has Limited Benefit for Moderate COVID-19

Randomized phase II trial shows no drop in progression to severe disease, all-cause deaths
Vaccination coverage with many recommended vaccines is high by age 24 months

CDC: Vaccination Coverage Generally High by Age 24 Months

Coverage with at least two doses of flu vaccine higher for children born 2016 to 2017 versus 2014 to 2015

American College of Surgeons, Oct. 3-7

The 105th Annual American College of Surgeons Clinical Congress The annual meeting of the American College of Surgeons was held virtually this...
Chemotherapy-free induction and consolidation first-line treatment with dasatinib and blinatumomab is associated with a high incidence of molecular response and survival in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

Dasatinib + Blinatumomab Active for Ph-Positive ALL in Adults

Complete remission, overall survival seen in 98, 95 percent of patients in phase 2 study
For women with breast cancer

Taking Lipid-Lowering Meds Tied to Lower Risk for Cancer Death

Adherence inversely linked to mortality related to breast cancer, CRC, melanoma in women
For moderately ill hospitalized patients with COVID-19

Tocilizumab Does Not Prevent Intubation, Death in COVID-19

Intubation or death, disease worsening similar for tocilizumab, placebo in hospitalized patients
The first company to start a phase 3 trial of a COVID-19 vaccine reached its target of enrolling 30

U.S. COVID-19 Vaccine Trial Enrolls 30,000

Moderna says it is on track to apply for FDA approval to market the vaccine in early December